Vanguard Group’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$17.7M Buy
6,318,285
+355,438
+6% +$1.27M ﹤0.01% 2674
2025
Q3
$28.6M Sell
5,962,847
-2,066,190
-26% -$13.1M ﹤0.01% 2448
2025
Q2
$73.1M Sell
8,029,037
-1,127,722
-12% -$8.31M ﹤0.01% 1959
2025
Q1
$82.7M Buy
9,156,759
+241,003
+3% +$2.54M ﹤0.01% 1876
2024
Q4
$117M Buy
8,915,756
+107,092
+1% +$1.43M ﹤0.01% 1808
2024
Q3
$138M Buy
8,808,664
+193,212
+2% +$2.93M ﹤0.01% 1733
2024
Q2
$116M Sell
8,615,452
-134,414
-2% -$2.75M ﹤0.01% 1762
2024
Q1
$242M Buy
8,749,866
+162,182
+2% +$3.6M ﹤0.01% 1398
2023
Q4
$165M Sell
8,587,684
-5,220
-0.1% -$94.5K ﹤0.01% 1609
2023
Q3
$139M Buy
8,592,904
+25,891
+0.3% +$460K ﹤0.01% 1632
2023
Q2
$163M Sell
8,567,013
-146,483
-2% -$2.61M ﹤0.01% 1572
2023
Q1
$127M Buy
8,713,496
+131,024
+2% +$2.35M ﹤0.01% 1705
2022
Q4
$168M Buy
8,582,472
+316,305
+4% +$6.17M ﹤0.01% 1525
2022
Q3
$199M Buy
8,266,167
+126,389
+2% +$3.89M 0.01% 1387
2022
Q2
$256M Buy
8,139,778
+71,281
+0.9% +$2.58M 0.01% 1277
2022
Q1
$355M Buy
8,068,497
+61,721
+0.8% +$2.65M 0.01% 1187
2021
Q4
$348M Sell
8,006,776
-128,803
-2% -$5.05M 0.01% 1241
2021
Q3
$255M Buy
8,135,579
+136,670
+2% +$5.38M 0.01% 1448
2021
Q2
$339M Buy
7,998,909
+1,672,001
+26% +$65M 0.01% 1257
2021
Q1
$238M Buy
6,326,908
+410,184
+7% +$12.8M 0.01% 1487
2020
Q4
$160M Buy
5,916,724
+1,033,893
+21% +$26.6M ﹤0.01% 1591
2020
Q3
$123M Sell
4,882,831
-211,083
-4% -$3.08M ﹤0.01% 1585
2020
Q2
$38.8M Sell
5,093,914
-88,144
-2% -$645K ﹤0.01% 2129
2020
Q1
$47.4M Sell
5,182,058
-110,093
-2% -$664K ﹤0.01% 1890
2019
Q4
$27.4M Buy
5,292,151
+198,633
+4% +$1.28M ﹤0.01% 2388
2019
Q3
$29.6M Buy
5,093,518
+338,219
+7% +$1.52M ﹤0.01% 2299
2019
Q2
$15.2M Sell
4,755,299
-2,316,978
-33% -$7.9M ﹤0.01% 2650
2019
Q1
$29M Buy
7,072,277
+1,173,172
+20% +$7.42M ﹤0.01% 2335
2018
Q4
$37.3M Sell
5,899,105
-482,416
-8% -$5.01M ﹤0.01% 2161
2018
Q3
$105M Buy
6,381,521
+33,197
+0.5% +$564K ﹤0.01% 1776
2018
Q2
$106M Buy
6,348,324
+289,788
+5% +$4.69M ﹤0.01% 1747
2018
Q1
$94.2M Buy
6,058,536
+324,021
+6% +$5.78M ﹤0.01% 1749
2017
Q4
$108M Buy
5,734,515
+30,460
+0.5% +$675K ﹤0.01% 1666
2017
Q3
$167M Buy
5,704,055
+22,976
+0.4% +$679K 0.01% 1399
2017
Q2
$183M Sell
5,681,079
-516,735
-8% -$17M 0.01% 1289
2017
Q1
$214M Sell
6,197,814
-290,246
-4% -$10.4M 0.01% 1168
2016
Q4
$229M Buy
6,488,060
+191,416
+3% +$6.47M 0.01% 1085
2016
Q3
$219M Sell
6,296,644
-309,649
-5% -$10.8M 0.01% 1053
2016
Q2
$247M Buy
6,606,293
+540,012
+9% +$20.3M 0.02% 932
2016
Q1
$245M Buy
6,066,281
+852,503
+16% +$31.8M 0.02% 909
2015
Q4
$188M Buy
5,213,778
+375,051
+8% +$13.6M 0.01% 1055
2015
Q3
$155M Buy
4,838,727
+179,374
+4% +$6.11M 0.01% 1150
2015
Q2
$158M Buy
4,659,353
+118,437
+3% +$3.99M 0.01% 1219
2015
Q1
$154M Buy
4,540,916
+162,992
+4% +$5.68M 0.01% 1196
2014
Q4
$154M Buy
4,377,924
+100,384
+2% +$3.38M 0.01% 1132
2014
Q3
$140M Buy
4,277,540
+50,971
+1% +$1.73M 0.01% 1140
2014
Q2
$144M Buy
4,226,569
+64,171
+2% +$2.2M 0.01% 1161
2014
Q1
$146M Buy
4,162,398
+44,914
+1% +$1.58M 0.01% 1111
2013
Q4
$151M Buy
4,117,484
+187,078
+5% +$6.87M 0.01% 1062
2013
Q3
$136M Buy
3,930,406
+107,325
+3% +$3.76M 0.01% 1048
2013
Q2
$129M Buy
+3,823,081
New +$127M 0.01% 1001

Other funds holding ACH

Vanguard Group's ACH Position: Q4 2025 in Review

Vanguard Group increased its Accendra Health (ACH) stake by 6% in Q4 2025, buying an estimated $1.27M and bringing the position to 6,318,285 shares worth $17.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2674.

Vanguard Group first reported a position in ACH in Q2 2013 and has held it in 51 quarters since. The position peaked at $355M in Q1 2022. 168 funds tracked by Wall St. Rank hold ACH as of Q4 2025.

  • Vanguard Group held 6,318,285 shares of Accendra Health worth $17.7M as of Q4 2025.
  • Vanguard Group bought 355,438 Accendra Health shares in Q4 2025, an estimated $1.27M.
  • Accendra Health made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #2674 holding.
  • Vanguard Group first reported a position in Accendra Health in Q2 2013 and has held it in 51 quarters since.
  • Vanguard Group's Accendra Health position peaked at $355M in Q1 2022.
  • 168 funds tracked by Wall St. Rank held Accendra Health as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.